Johnson Matthey (LON:JMAT) Insider Purchases £252,530.06 in Stock

Johnson Matthey PLC (LON:JMATGet Free Report) insider Liam Condon purchased 10,951 shares of the firm’s stock in a transaction dated Friday, September 11th. The stock was acquired at an average cost of GBX 2,306 per share, with a total value of £252,530.06.

Liam Condon also recently made the following trade(s):

  • On Friday, July 10th, Liam Condon acquired 14 shares of Johnson Matthey stock. The shares were acquired at an average price of GBX 1,909 per share, for a total transaction of £267.26.

Johnson Matthey Stock Performance

Shares of LON JMAT opened at GBX 2,284 on Thursday. The company has a quick ratio of 0.76, a current ratio of 1.56 and a debt-to-equity ratio of 69.69. The firm’s 50-day moving average price is GBX 2,130.73 and its two-hundred day moving average price is GBX 2,061.46. Johnson Matthey PLC has a 52-week low of GBX 2,192 and a 52-week high of GBX 3,245.33. The stock has a market capitalization of £2.88 billion, a P/E ratio of -29.95, a P/E/G ratio of 49,242.50 and a beta of 0.93.

Wall Street Analysts Forecast Growth

A number of research analysts recently commented on JMAT shares. Jefferies Financial Group restated a “buy” rating and set a GBX 2,330 price objective on shares of Johnson Matthey in a research note on Tuesday, August 4th. UBS Group reiterated a “neutral” rating and issued a GBX 2,200 price objective on shares of Johnson Matthey in a research report on Friday, May 22nd. Deutsche Bank Aktiengesellschaft restated a “buy” rating and issued a GBX 2,400 target price on shares of Johnson Matthey in a research report on Monday, July 6th. Finally, Berenberg Bank raised their price target on shares of Johnson Matthey from GBX 2,100 to GBX 2,300 and gave the company a “buy” rating in a research note on Monday, June 1st. Four analysts have rated the stock with a Buy rating and two have assigned a Hold rating to the stock. According to MarketBeat.com, the stock has an average rating of “Moderate Buy” and a consensus price target of GBX 2,283.33.

View Our Latest Research Report on JMAT

Johnson Matthey Company Profile

(Get Free Report)

Johnson Matthey is a global leader in science that enables a cleaner and healthier world. With over 200 years of sustained commitment to innovation and technological breakthroughs, they improve the function, performance and safety of their customers’ products. Their science has a global impact in areas such as low emission transport, pharmaceuticals, chemical processing and making the most efficient use of the planet’s natural resources. Today more than 13,000 Johnson Matthey professionals collaborate with their network of customers and partners to make a real difference to the world around us.

Featured Stories

Insider Buying and Selling by Quarter for Johnson Matthey (LON:JMAT)

Receive News & Ratings for Johnson Matthey Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Johnson Matthey and related companies with MarketBeat.com's FREE daily email newsletter.